Madam, Identification of hepatitis C virus (HCV) as a major causative organism of non-A, non-B hepatitis (NANBH) in the late 1980’s and the development of a screening test has led to the introduction of routine tests for antibodies to HCV in 1991 in the U. K. and U.S.A¹. In Pakistan, apart from few voluntary blood bank services who have incorporated anti-HCV screening in 1994, majority of blood banks and transfusion services do not routinely perform pre-transfusion testing on all donations whether they are voluntary unpaid, directed donations or paid professional blood donations. A study was conducted to screen 135 registered professional blood donors for Hbs Ag and Anti­ HCV, in our hospital. Hepatitis B was tested by a third generation ELISA while hepatitis C by second generation ELISA technique (Abbott’s Diagnostic Division). All positive donors were informed of their results and rejected for further donations. Of the 135 professional male blood donors, between 20-50 years of age, 43(31.8%) reacted positively for FIBs Ag and anti-HCV. HBs Ag was reactive in 14(10.4%), ant-HCV in28 (20.7%) and 1(0.7%) was seropositive for both. HIV was non-reactive in all. Blood transfusion is an important and established source of transmitting viral diseases to the recipient². Transfusion of unscreened blood products from professional blood donors has a 30% chance of transmitting these viruses to the recipients³. The seroconversion rate for HCV in the recipients is 40-93%and is a major cause of post-transfusion hepatitis^1-5. This study performed in one hospital gave a sero positive result in 30 percent donors. A high prevalence of HBV and HCV in our population makes screening of blood before transfusion mandatory. Funds for the purpose should be provided by the government and NGOS.

A.Ahmed, T. S. Shamsi, S. Hafiz, K. Z. Hashmi, M. N. Zafar and S. Syed.
Dr. Ziauddin Hospital, North Nazitnabad, Karachi.

1. Ayob, Y., Davidson, J., Baxter, A. al. Risk of hepatitis C in patients who received blood from donors subsequently shown to be carriers of hepatitis C virus. Transfusion, 1994;4:269.72.
2. Hoffbrand, A.V and Petit, i.E. Essential haematology. 3rd ed., Oxford, B lacwell Scientific Publications, 1993, pp.401-402.
3. Aoki, S.K., Holland, P.V., Fernando, L.P. et al. Evidence of hepatitis in patients receiving transfusion of blood components containing antibody to hepatitis C. Blood, 1993;82: 1000-5.
4. Van der Pol, CL.. Reesink, H.W, Schaasberg, W. et al. Infectivity of blood seropositive for hepatitis C virus antibodies. Lancet, 1990;335:558-60.
5. Esteban, J.I., Esteban, R., Viladmiu, L. et al Hepatitis C virus antibodies among risk groups in Spain. Lancet, 1989;11:294-7.